Company chart and information is provided by TradingView based on 15-minute-delayed data.
IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
| Website: | www.imv-inc.com |
| Email: | info@imv-inc.com |
| Main Phone: | +1 902 492-1819 |
| Address: | 130 Eileen Stubbs Avenue |
| Address 2: | Suite 19 |
| State: | NS |
| City / Town: | Dartmouth |
| Country: | CA |
| Postal Code: | B3B 2C4 |
| Exchange: | NSC |
| CEO: | Frederic Ors |
| Employees: | 77 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
